Six current analyst price targets were reviewed. They span a low of $8.00 (Shervin Zand, initiated coverage in September 2026) to a high of $11.25 (Craig Hallum, reiterated August 2026). The middle of the range is crowded: TD Cowen's Shaul Eyal, Lake Street's Eric Martinuzzi, and Northland Securities' Michael Latimore each carry a $10.00 target, while Cantor Fitzgerald's Brett Knoblauch holds $9.00. The arithmetic mean of these six figures is about $9.71, rounded here to a central target of $9.70.
The overall consensus is bullish, with most sources citing a "Strong Buy" or "Moderate Buy" rating. Analysts generally point to accelerating annual recurring revenue (ARR), expanding multi-year contracts, and improving operating efficiency. The notable spread between $8.00 and $11.25 reflects disagreement over how quickly EVLV can convert strong top-line growth into sustained profitability. Notably, one downgrade was recorded in May 2026, and several earlier targets were raised during 2025 as the company beat quarterly expectations. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of its most recent close, EVLV traded near $4.76, giving the company a market capitalization of roughly $862 million. Its 52-week range is approximately $4.02 to $7.48. Reaching the $9.70 central target would require a gain of roughly 104% from current levels—a very large move that would take the stock well above its existing 52-week high.
The path would likely depend on sustained revenue growth, a demonstrated turn toward positive earnings, and investor willingness to pay a richer multiple. Trailing twelve-month revenue reached about $171 million, up more than 40% year over year, but the company remained modestly unprofitable with diluted EPS (earnings per share) of about negative $0.03. Management has raised 2026 revenue guidance to a range of roughly $172 million to $178 million, but the stock's YTD decline of more than 30% suggests investors are currently discounting execution risk.
The strongest support comes from demand. EVLV has secured multi-year partnerships with school districts, hospitals, and high-profile sports and entertainment venues, and it continues to deploy its Evolv Express and Evolv eXpedite screening products. Analysts have highlighted the company's shift toward direct subscriptions, which improves ARR per unit and revenue visibility.
The resolution of legal and regulatory overhangs—including the termination of a Department of Justice investigation and a cost-minimized class action settlement—removed a meaningful drag on sentiment. Rising ARR momentum, combined with narrowing losses, underpins the bullish view that EVLV could re-rate higher if profitability becomes more visible.
EVLV remains loss-making on a GAAP (generally accepted accounting principles) basis, and profitability is not yet assured. The stock trades at a price-to-sales ratio near 4.8, which some independent valuation models consider expensive for a company still generating negative earnings. Insiders, including the founder, have been net sellers, and major early investors such as General Catalyst exited positions in 2025.
Macroeconomic pressure on school and municipal budgets, competition in the security-screening market, and a high beta near 1.8 all add risk. If revenue growth slows or margins disappoint, the multiple could compress further rather than expand toward the analyst targets. From what I see, this remains a key area to monitor closely.
EVLV has traded between roughly $4.02 and $7.48 over the past 52 weeks. The $4.02–$4.20 zone has acted as recent support, with the stock bouncing from an October 2026 low. On the upside, the $7.48 52-week high represents a key resistance level, and the $5.00 psychological round number sits between the current price and that high. The central $9.70 target lies well above any level the stock has reached in the past year, underscoring the scale of the move required. I’m watching this closely for any breakouts or breakdowns.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual analysts may apply different timeframes. Investors should monitor quarterly earnings—including the report due around November 10, 2026—along with ARR growth, gross margin trends, and progress toward GAAP profitability. Revenue guidance updates, new contract announcements, insider and institutional share activity, and any analyst target revisions are also important signals.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than replacing judgment, the tool helps traders discover opportunities, track existing positions, and spot emerging trend changes more efficiently. Traders following a volatile name like EVLV can use these signals to stay alert to shifting momentum and supplement their own research. In my view, layering this into routine analysis adds a useful layer of objective input without overriding individual strategy.
The $9.70 central target for Evolv Technologies Holdings is the average of six analyst targets ranging from $8.00 to $11.25. At a price near $4.76, reaching that level would require roughly a 104% advance—an ambitious move driven by the view that rapid revenue growth will eventually convert into profitability. Support comes from strong ARR momentum, raised guidance, and cleared legal overhangs, while the main obstacles are persistent losses, a rich valuation, insider selling, and execution risk. Whether the stock can reach the target will hinge on sustained top-line growth, margin improvement, and a re-rating by the market—none of which is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for EVLV moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 28 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EVLV as a result. In 55 of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for EVLV just turned positive on October 21, 2026. Looking at past instances where EVLV's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
EVLV moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVLV advanced for three days, in 207 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
EVLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where EVLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for EVLV entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EVLV's P/B Ratio (6.949) is slightly higher than the industry average of (2.996). EVLV's P/E Ratio (-228.000) is considerably lower than the industry average of (3.471). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.749). Dividend Yield (0.000) settles around the average of (0.244) among similar stocks. EVLV's P/S Ratio (5.189) is slightly higher than the industry average of (2.085).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. EVLV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributor of products to consumers through TV, telephone, online and mobile
Industry MiscellaneousCommercialServices